Characteristics and history by study
| Total | Elisa-3 | Elisa registry | p Value | |
|---|---|---|---|---|
| Randomisation everolimus | 234/474 (49.4%) | 87/178 (48.9%) | 147/296 (49.7%) | 0.868 |
| Male gender | 351/474 (74.1%) | 136/178 (76.4%) | 215/296 (72.6%) | 0.365 |
| Hypertension | 226/474 (47.7%) | 91/178 (51.1%) | 135/296 (45.6%) | 0.244 |
| Previous MI | 69/473 (14.6%) | 28/178 (15.7%) | 41/295 (13.9%) | 0.584 |
| Previous CABG | 47/474 (9.9%) | 22/178 (12.4%) | 25/296 (8.4%) | 0.167 |
| Previous PCI | 70/474 (14.8%) | 30/178 (16.9%) | 40/296 (13.5%) | 0.321 |
| Previous stroke | 21/474 (4.4%) | 6/178 (3.4%) | 15/296 (5.1%) | 0.385 |
| Previous TIA | ||||
| Diabetes Mellitus | 85/474 (17.9%) | 34/178 (19.1%) | 51/296 (17.2%) | 0.607 |
| Smoking | 167/473 (35.3%) | 53/178 (29.8%) | 114/295 (38.6%) | 0.051 |
| Family history | 200/472 (42.4%) | 72/176 (40.9%) | 128/296 (43.2%) | 0.620 |
CABG, coronary artery bypass graft; MI, myocardial infarction; PCI, percutaneous coronary intervention.